381 related articles for article (PubMed ID: 15585834)
21. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
22. CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas TL; Bakker CY; Bluestone JA
J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
[TBL] [Abstract][Full Text] [Related]
23. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation.
Gonzalo JA; Delaney T; Corcoran J; Goodearl A; Gutierrez-Ramos JC; Coyle AJ
J Immunol; 2001 Jan; 166(1):1-5. PubMed ID: 11123268
[TBL] [Abstract][Full Text] [Related]
24. CD28-specific antibody prevents graft-versus-host disease in mice.
Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
[TBL] [Abstract][Full Text] [Related]
25. CD28 function: a balance of costimulatory and regulatory signals.
Bour-Jordan H; Blueston JA
J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
[TBL] [Abstract][Full Text] [Related]
26. A role for CD28 in lymphopenia-induced proliferation of CD4 T cells.
Hagen KA; Moses CT; Drasler EF; Podetz-Pedersen KM; Jameson SC; Khoruts A
J Immunol; 2004 Sep; 173(6):3909-15. PubMed ID: 15356139
[TBL] [Abstract][Full Text] [Related]
27. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?
Linsley PS
J Exp Med; 1995 Aug; 182(2):289-92. PubMed ID: 7543133
[No Abstract] [Full Text] [Related]
28. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
29. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.
Wagner DH; Hagman J; Linsley PS; Hodsdon W; Freed JH; Newell MK
J Exp Med; 1996 Nov; 184(5):1631-8. PubMed ID: 8920853
[TBL] [Abstract][Full Text] [Related]
30. Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES.
Hidi R; Riches V; Al-Ali M; Cruikshank WW; Center DM; Holgate ST; Djukanovic R
J Immunol; 2000 Jan; 164(1):412-8. PubMed ID: 10605037
[TBL] [Abstract][Full Text] [Related]
31. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
32. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
[TBL] [Abstract][Full Text] [Related]
33. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system.
Anderson DE; Sharpe AH; Hafler DA
Curr Opin Immunol; 1999 Dec; 11(6):677-83. PubMed ID: 10631554
[TBL] [Abstract][Full Text] [Related]
34. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
[TBL] [Abstract][Full Text] [Related]
35. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.
Yi Y; McNerney M; Datta SK
J Immunol; 2000 Dec; 165(11):6627-34. PubMed ID: 11086108
[TBL] [Abstract][Full Text] [Related]
36. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
Chang TT; Kuchroo VK; Sharpe AH
Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
[No Abstract] [Full Text] [Related]
37. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
38. CTLA-4Ig: uses and future directions.
Ben-Shoshan M
Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):132-42. PubMed ID: 19519590
[TBL] [Abstract][Full Text] [Related]
39. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
Metz DP; Farber DL; Taylor T; Bottomly K
J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
[TBL] [Abstract][Full Text] [Related]
40. Cbl-b regulates the CD28 dependence of T-cell activation.
Chiang YJ; Kole HK; Brown K; Naramura M; Fukuhara S; Hu RJ; Jang IK; Gutkind JS; Shevach E; Gu H
Nature; 2000 Jan; 403(6766):216-20. PubMed ID: 10646609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
